Late toxicities burden in patients with radioiodine-refractory differentiated thyroid cancer treated with lenvatinib

被引：0
|
作者：
F. Platini
S. Cavalieri
S. Alfieri
C. Bergamini
C. Resteghini
A. Bottiglieri
E. Colombo
L. Mazzeo
L. Licitra
B. Paolini
E. Seregni
L. D. Locati
机构：
[1] Fondazione IRCCS Istituto Nazionale dei Tumori,Head and Neck Cancer Medical Oncology Unit
[2] University of Milan,Medical Oncology Department
[3] Fondazione IRCCS Istituto Nazionale dei Tumori,Pathology Department
[4] Fondazione IRCCS Istituto Nazionale dei Tumori,Struttura di Terapia Medico Nucleare ed Endocrinologia U.O. Medicina Nucleare
来源：
Endocrine | 2021年 / 73卷
关键词：
Thyroid cancer; RAI-resistant; Lenvatinib; Late toxicities;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：641 / 647
页数：6
相关论文
共 50 条
  • [21] Clinical use of lenvatinib in patients with previous renal and/or hepatic impairment and radioiodine-refractory differentiated thyroid cancer
    Martinez-Trufero, Javier
    [J]. CANCER MEDICINE, 2022, 11 : 5 - 9
  • [22] Impact of baseline tumor burden on overall survival in patients with radioiodine-refractory differentiated thyroid cancer treated with lenvatinib in the SELECT global phase 3 trial
    Kiyota, Naomi
    Tahara, Makoto
    Robinson, Bruce
    Schlumberger, Martin
    Sherman, Steven, I
    Leboulleux, Sophie
    Lee, Eun Kyung
    Suzuki, Takuya
    Ren, Min
    Fushimi, Kazuma
    Wirth, Lori J.
    [J]. CANCER, 2022, 128 (12) : 2281 - 2287
  • [23] COST EFFECTIVENESS OF LENVATINIB, SORAFENIB, AND PLACEBO IN TREATMENT OF RADIOIODINE-REFRACTORY DIFFERENTIATED THYROID CANCER
    Huang, W.
    Chen, L.
    Cao, V
    Sung, H.
    Yokokura, M.
    Ting, J.
    Wilson, L.
    [J]. VALUE IN HEALTH, 2016, 19 (03) : A204 - A204
  • [24] Managing the adverse events associated with lenvatinib therapy in radioiodine-refractory differentiated thyroid cancer
    Cabanillas, Maria E.
    Takahashi, Shunji
    [J]. SEMINARS IN ONCOLOGY, 2019, 46 (01) : 57 - 64
  • [25] Cost Effectiveness of Lenvatinib, Sorafenib and Placebo in Treatment of Radioiodine-Refractory Differentiated Thyroid Cancer
    Wilson, Leslie
    Huang, Wei
    Chen, Linda
    Ting, Jie
    Cao, Vicky
    [J]. THYROID, 2017, 27 (08) : 1043 - 1052
  • [26] Prognostic Roles of Inflammatory Biomarkers in Radioiodine-Refractory Thyroid Cancer Treated with Lenvatinib
    Kim, Chae A.
    Kim, Mijin
    Jin, Meihua
    Kim, Hee Kyung
    Jeon, Min Ji
    Lim, Dong Jun
    Kim, Bo Hyun
    Kang, Ho-Cheol
    Kim, Won Bae
    Shin, Dong Yeob
    Kim, Won Gu
    [J]. ENDOCRINOLOGY AND METABOLISM, 2024, 39 (02) : 334 - 343
  • [27] Subgroup analysis of Japanese patients in a phase 3 study of lenvatinib in radioiodine-refractory differentiated thyroid cancer
    Kiyota, Naomi
    Schlumberger, Martin
    Muro, Kei
    Ando, Yuichi
    Takahashi, Shunji
    Kawai, Yasukazu
    Wirth, Lori
    Robinson, Bruce
    Sherman, Steven
    Suzuki, Takuya
    Fujino, Katsuki
    Gupta, Anubha
    Hayato, Seiichi
    Tahara, Makoto
    [J]. CANCER SCIENCE, 2015, 106 (12) : 1714 - 1721
  • [28] Exposure–response analysis and simulation of lenvatinib safety and efficacy in patients with radioiodine-refractory differentiated thyroid cancer
    Seiichi Hayato
    Robert Shumaker
    Jim Ferry
    Terri Binder
    Corina E. Dutcus
    Ziad Hussein
    [J]. Cancer Chemotherapy and Pharmacology, 2018, 82 : 971 - 978
  • [29] Lenvatinib for the Treatment of Radioiodine-Refractory Differentiated Thyroid Cancer: Treatment Optimization for Maximum Clinical Benefit
    Wirth, Lori J.
    Durante, Cosimo
    Topliss, Duncan J.
    Winquist, Eric
    Robenshtok, Eyal
    Iwasaki, Hiroyuki
    Luster, Markus
    Elisei, Rossella
    Leboulleux, Sophie
    Tahara, Makoto
    [J]. ONCOLOGIST, 2022, 27 (07): : 565 - 572
  • [30] Use of lenvatinib in the treatment of radioiodine-refractory differentiated thyroid cancer: a multidisciplinary perspective for daily practice
    Capdevila, Jaume
    Deandreis, Desiree'
    Durante, Cosimo
    Leboulleux, Sophie
    Luster, Markus
    Netea-Maier, Romana
    Newbold, Kate
    Singer, Susanne
    Sykiotis, Gerasimos P.
    Bartes, Beate
    Farnell, Kate
    Locati, Laura Deborah
    [J]. EUROPEAN THYROID JOURNAL, 2023, 12 (05)
12345